Walter E. Washington Convention Center
Washington, D.C.
May 16-19, 2022


  • Booth: 569

Welcome to Polyplus-transfection's page!

Polyplus-transfection applies its 20 years expertise to the development of novel transfection solutions. Polyplus-transfection is the leading supplier of a key critical component for viral vectors manufacturing for Gene & Cell Therapy. We are proud to provide qualified and GMP-grade transfection reagents suitable from R&D to clinical trial and commercial scale, accompanied by a strong scientific and regulatory support. In addition, we provide a range of effective transfection reagents to deliver most nucleic acids, including DNA and siRNA in vitro and in vivo.

Brands: Transfection reagents to support Cell & Gene Therapy


  • FectoVIR®-AAV
    FectoVIR®-AAV is a novel class of animal free transfection reagent specifically developed for industrial scale production of recombinant AAV (rAAV) viral vectors in suspension HEK-293 cell types.

  • FectoVIR®-AAV transfection reagent is a novel chemical-based and animal-free transfection reagent that has been engineered to address the current limits in rAAV viral vector yields and industrial scalability. FectoVIR®-AAV transfection reagent is the outcome of an extensive development process in which candidates from our proprietary internal chemical library were tested in comparison to the gold standard for virus production, our PEIpro® transfection reagent. In comparison to PEIpro® and other competitors, FectoVIR®-AAV stands out with its unmatched performance for the production of rAAV viral vectors in suspension cell culture systems:

    • Designed for Gene Therapy: RUO and cGMP grade for process development to commercialization
    • Superior Performance: highest AAV titers to increase dose number per batch
    • Scalable: robust and flexible for small to large scale production
    • Cost-effective: reduce cost per dose for therapy affordability
    • Accelerate time to market: combine performance and scalability for speedy process development
    • Trustworthy: access to our Gene therapy scientific, regulatory and supply chain support